1. Home
  2. /
  3. Investments
  4. /
  5. Cell-Easy

Cell-Easy

Cell-Easy is a stem cell Contract Development and Manufacturing Organization (CDMO) that provides quick and easy access to ready-to-inject adipose-derived allogeneic stem cells for preclinical and clinical drug development projects.

Their production process has been optimized under cGMP conditions and inspected by the French National Agency of Medicine and Health Products Safety (ANSM), in order to be scalable and guarantee optimal product safety, quality and efficacy for patients.

Cell-Easy vectoriel
Team

Venture Capital

Status

Current

Geography

Europe

Financing Round

Financing round - Series A

Segment

Pharma Services

Entry Date

2020

Key Figures

Current

Status

2015

Creation Date

14

Number of Employees

2020

Investment Date

OMX Europe Venture Fund

Fund Name

Key Contacts

Related companies